BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mcelhaney JE, Herre JM, Lawson M, Cole SK, Burke BL, Hooton JW. Effect of congestive heart failure on humoral and ex vivo cellular immune responses to influenza vaccination in older adults. Vaccine 2004;22:681-8. [DOI: 10.1016/j.vaccine.2003.08.032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Verschoor CP, Lelic A, Parsons R, Evelegh C, Bramson JL, Johnstone J, Loeb MB, Bowdish DME. Serum C-Reactive Protein and Congestive Heart Failure as Significant Predictors of Herpes Zoster Vaccine Response in Elderly Nursing Home Residents. J Infect Dis 2017;216:191-7. [PMID: 28838148 DOI: 10.1093/infdis/jix257] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
2 Barbieri M, Capri S, Waure C, Boccalini S, Panatto D. Age- and risk-related appropriateness of the use of available influenza vaccines in the Italian elderly population is advantageous: results from a budget impact analysis. J Prev Med Hyg 2017;58:E279-87. [PMID: 29707658 DOI: 10.15167/2421-4248/jpmh2017.58.4.867] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
3 Mcelhaney JE, Hooton JW, Hooton N, Bleackley RC. Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults. Vaccine 2005;23:3294-300. [DOI: 10.1016/j.vaccine.2005.01.080] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
4 Bhatt AS, DeVore AD, Hernandez AF, Mentz RJ. Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions. JACC Heart Fail 2017;5:194-203. [PMID: 28161238 DOI: 10.1016/j.jchf.2016.12.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
5 Mcelhaney JE. The unmet need in the elderly: Designing new influenza vaccines for older adults. Vaccine 2005;23:S10-25. [DOI: 10.1016/j.vaccine.2005.04.019] [Cited by in Crossref: 120] [Cited by in F6Publishing: 115] [Article Influence: 7.1] [Reference Citation Analysis]
6 Keynan Y, Card CM, Ball BT, Li Y, Plummer FA, Fowke KR. Cellular immune responses to recurring influenza strains have limited boosting ability and limited cross-reactivity to other strains. Clin Microbiol Infect 2010;16:1179-86. [PMID: 20670292 DOI: 10.1111/j.1469-0691.2010.03142.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
7 Keshtkar-Jahromi M, Vakili H, Rahnavardi M, Gholamin S, Razavi SM, Eskandari A, Sadeghi R, Vatan-Pour H, Keshtkar-Jahromi M, Haghighat B, Ghaffaripour M, Mokhtari-Azad T. Antibody response to influenza immunization in coronary artery disease patients: a controlled trial. Vaccine 2009;28:110-3. [PMID: 19819210 DOI: 10.1016/j.vaccine.2009.09.108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Verschoor CP, Andrew MK, Loeb M, Pawelec G, Haynes L, Kuchel GA, McElhaney JE. Antibody and Cell-Mediated Immune Responses Are Correlates of Protection against Influenza Infection in Vaccinated Older Adults. Vaccines (Basel) 2021;9:25. [PMID: 33430191 DOI: 10.3390/vaccines9010025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Almanzar G, Herndler-brandstetter D, Chaparro SV, Jenewein B, Keller M, Grubeck-loebenstein B. Immunodominant peptides from conserved influenza proteins – A tool for more efficient vaccination in the elderly? Wien Med Wochenschr 2007;157:116-21. [DOI: 10.1007/s10354-007-0393-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
10 Mehta J, Walsh EE, Mahadevia PJ, Falsey AR. Risk Factors for Respiratory Syncytial Virus Illness Among Patients with Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease 2013;10:293-9. [DOI: 10.3109/15412555.2012.744741] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
11 Albrecht CM, Sweitzer NK, Johnson MR, Vardeny O. Lack of persistence of influenza vaccine antibody titers in patients with heart failure. J Card Fail 2014;20:105-9. [PMID: 24361852 DOI: 10.1016/j.cardfail.2013.12.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
12 Burchard GD, Caumes E, Connor BA, Freedman DO, Jelinek T, Jong EC, von Sonnenburg F, Steffen R, Tsai TF, Wilder-Smith A, Zuckerman J. Expert opinion on vaccination of travelers against Japanese encephalitis. J Travel Med 2009;16:204-16. [PMID: 19538583 DOI: 10.1111/j.1708-8305.2009.00330.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
13 Shaw SM, Williams SG, Yonan N, Fildes JE. Decreased immune responses to influenza vaccination in patients with heart failure. J Card Fail 2009;15:549; author reply 549-51. [PMID: 19643367 DOI: 10.1016/j.cardfail.2009.05.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Vardeny O, Moran JJ, Sweitzer NK, Johnson MR, Hayney MS. Decreased T-cell responses to influenza vaccination in patients with heart failure. Pharmacotherapy 2010;30:10-6. [PMID: 20030468 DOI: 10.1592/phco.30.1.10] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
15 Vardeny O, Sweitzer NK, Detry MA, Moran JM, Johnson MR, Hayney MS. Decreased immune responses to influenza vaccination in patients with heart failure. J Card Fail 2009;15:368-73. [PMID: 19398087 DOI: 10.1016/j.cardfail.2008.11.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
16 Hayney MS, Welter DL, Francois M, Reynolds AM, Love RB. Influenza Vaccine Antibody Responses in Lung Transplant Recipients. Prog Transpl 2004;14:346-51. [DOI: 10.1177/152692480401400410] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
17 Hui SL, Chu LW, Peiris JS, Chan KH, Chu D, Tsui W. Immune response to influenza vaccination in community-dwelling Chinese elderly persons. Vaccine 2006;24:5371-80. [PMID: 16713661 DOI: 10.1016/j.vaccine.2006.04.032] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
18 Van Ermen A, Hermanson MP, Moran JM, Sweitzer NK, Johnson MR, Vardeny O. Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study. Eur J Heart Fail 2013;15:560-4. [PMID: 23291729 DOI: 10.1093/eurjhf/hfs207] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
19 Senchina DS, Kohut ML. Immunological outcomes of exercise in older adults. Clin Interv Aging 2007;2:3-16. [PMID: 18044072 DOI: 10.2147/ciia.2007.2.1.3] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
20 Behrouzi B, Araujo Campoverde MV, Liang K, Talbot HK, Bogoch II, McGeer A, Fröbert O, Loeb M, Vardeny O, Solomon SD, Udell JA. Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;76:1777-94. [PMID: 33032740 DOI: 10.1016/j.jacc.2020.08.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]